NCT03252938 2026-02-19
INSIGHT
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 1 Active not recruiting
Clinical Trials
10 trialsNCT04811027 2025-12-11
TACTI-003
Immutep S.A.S.
Phase 2 Completed
NCT03625323 2024-12-18
TACTI-002
Immutep S.A.S.
Phase 2 Completed
NCT05747794 2024-12-17
AIPAC-003
Immutep S.A.S.
Phase 2/3 Active not recruiting
NCT04252768 2023-03-22
AIPAC-002
Immutep S.A.S.
Phase 1 Withdrawn
NCT01308294 2020-06-11
LAG-3/IMP321
Centre Hospitalier Universitaire Vaudois
Phase 1/2 Terminated
NCT02676869 2019-12-18
TACTI-mel
Immutep Australia Pty. Ltd.
Phase 1 Completed
NCT00365937 2019-03-06
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1/2 Terminated
NCT00349934 2010-01-07
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Immutep S.A.S.
Phase 1 Completed
NCT00351949 2010-01-07
IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)
Immutep S.A.S.
Phase 1 Completed